Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
A A Pract ; 12(9): 332-335, 2019 May 01.
Article in English | MEDLINE | ID: mdl-30431443

ABSTRACT

In this case report, we describe 2 patients with septic shock requiring high-dose vasopressors for hemodynamic support despite aggressive fluid resuscitation. After the administration of high-dose hydroxocobalamin for presumed septic vasoplegic syndrome, both patients had an immediate response to hydroxocobalamin with a rapid and lasting improvement of blood pressure that significantly reduced the need for vasopressor support.


Subject(s)
Hydroxocobalamin/administration & dosage , Shock, Septic/complications , Vasoplegia/drug therapy , Blood Pressure/drug effects , Humans , Hydroxocobalamin/pharmacology , Male , Middle Aged , Shock, Septic/drug therapy , Treatment Outcome , Vasoplegia/etiology
2.
J Appl Physiol (1985) ; 113(2): 281-9, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22556399

ABSTRACT

INTRODUCTION: phenylephrine is used daily during anesthesia for treating hypotension. However, the effects of phenylephrine on cardiac output (CO) are not clear. We hypothesized that the impact of phenylephrine on cardiac output is related to preload dependency. METHODS: eight pigs were studied at a preload independent stage (after CO augmentation) and at a preload dependent stage (after a 21 ml/kg hemorrhage). At each stage, phenylephrine boluses (0.5, 1.0, 2.0, and 4.0 µg/kg) were given randomly while mean arterial pressure (MAP), CO, inferior vena cava flow (IVCf) (both measured using ultrasonic flow probes), and pulse pressure variation were measured. RESULTS: at the preload independent stage, phenylephrine boluses induced significant increases in MAP (from 72 ± 6 to 100 ± 6 mmHg; P < 0.05) and decreases in CO and IVCf (from 7.0 ± 0.8 to 6.0 ± 1.1 l/min and from 4.6 ± 0.5 to 3.8 ± 0.6 l/min, respectively). At the preload-dependent stage, phenylephrine boluses induced significant increases in MAP (from 40 ± 7 to 65 ± 9 mmHg), CO (from 4.1 ± 0.6 to 4.9 ± 0.7 l/min), and IVCf (from 3.0 ± 0.4 to 3.5 ± 0.6 l/min; all data presented are for 4 µg/kg). Incremental doses of phenylephrine induced incremental changes in cardiac output. A pulse pressure variation >16.4% before phenylephrine predicted an increase in stroke volume with a 93% sensitivity and a 100% specificity. CONCLUSION: impact of phenylephrine on cardiac output is related to preload dependency. When the heart is preload independent, phenylephrine boluses induce on average a decrease in cardiac output. When the heart is preload dependent, phenylephrine boluses induce on average an increase in cardiac output.


Subject(s)
Cardiac Output/drug effects , Cardiac Output/physiology , Phenylephrine/administration & dosage , Posture/physiology , Stroke Volume/drug effects , Stroke Volume/physiology , Veins/physiology , Animals , Cardiotonic Agents , Dose-Response Relationship, Drug , Swine , Veins/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...